 OUTLINE: This is a multicenter study. Patients are stratified by age 50-55 vs 56-59 vs 60-65 vs 66-69 years, Gleason score 2-4 vs 5-7 vs 8-10, and average result of Prostate Check Clinic and first biopsy prostate-specific antigen PSA tests 6 vs 6-9.9 vs 10 ngmL. Patients are either randomized to or select 1 of 3 treatment arms. 